Literature DB >> 26359806

The Use and the Prescription Pattern of Traditional Chinese Medicine Among Urolithiasis Patients in Taiwan: A Population-Based Study.

Po-Hung Lin1,2, Shun-Ku Lin3,4, Ren-Jun Hsu5,6, Kuan-Chen Cheng7,8, Jui-Ming Liu9.   

Abstract

OBJECTIVES: To investigate the pattern of Traditional Chinese Medicine (TCM) usage for urolithiasis patients in Taiwan and to determine the most common Chinese herbal products used for urolithiasis.
DESIGN: Retrospective review of urolithiasis patients treated with TCM treatment. SETTINGS/LOCATION: One million randomly selected samples in the Taiwanese National Health Insurance Research Database between 1997 and 2008. PATIENTS: Eighty-two thousand five hundred and fifty-one newly diagnosed urolithiasis patients. OUTCOME MEASURES: The correlation between TCM treatment, demographic factors, or medical conditions.
RESULTS: A total of 62.6% of urolithiasis patients use TCM treatment. A younger age, female gender, polypharmacy, multiple comorbidities, and stone in the lower urinary tract result in a greater tendency to use TCM, after adjusting for demographic factors. Jia-Wei-Xiao-Yao-San Extract Powder and Ji-Sheng-Shen-Qi-Wan Extract Powder are the most frequently prescribed Chinese medicine formulae.
CONCLUSION: This is the first study to examine the use of and the prescription pattern for TCM in urolithiasis patients using a random, national population-based sample. More than 62% of urolithiasis patients use TCM, and patients with polypharmacy, multiple comorbidities, and stone in the ureter are more likely to use TCM. The most frequently prescribed Chinese medicine formulae were Jia-Wei-Xiao-Yao-San Extract Powder and Ji-Sheng-Shen-Qi-Wan Extract Powder, which were reported to retard the progression of renal failure and alleviate flank pain or tenderness.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26359806     DOI: 10.1089/acm.2015.0116

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  6 in total

1.  Increased risk of endotracheal intubation and heart failure following acute myocardial infarction in patients with urolithiasis: a nationwide population-based study.

Authors:  Shun-Ku Lin; Jui-Ming Liu; Ying-Hsu Chang; Yuan-Tien Ting; See-Tong Pang; Ren-Jun Hsu; Po-Hung Lin
Journal:  Ther Clin Risk Manag       Date:  2017-02-23       Impact factor: 2.423

2.  Traditional Chinese medicine decreases the obstructive uropathy risk in uterovaginal prolapse: A nationwide population-based study.

Authors:  Yin-Jen Chang; Wen-Chi Chen; Jen-Huai Chiang; Yuan-Chih Su; Kao-Sung Tsai; Kee-Ming Man; Ming-Yen Tsai; Yung-Hsiang Chen; Huey-Yi Chen
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

3.  Traditional Chinese medicine therapy reduces the risk of total knee replacement in patients with knee osteoarthritis.

Authors:  Pei-Chia Lo; Fong-Cheng Lin; Yao-Chien Tsai; Shun-Ku Lin
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

4.  Effects of Chinese herbal medicines on the occurrence of diabetic retinopathy in type 2 diabetes patients and protection of ARPE-19 retina cells by inhibiting oxidative stress.

Authors:  Fuu-Jen Tsai; Te-Mao Li; Cheng-Hang Ko; Wen-Miin Liang; Ying-Ju Lin; Chi-Fung Cheng; Tsung-Jung Ho; Xiang Liu; Hsinyi Tsang; Ting-Hsu Lin; Chiu-Chu Liao; Ju-Pi Li; Shao-Mei Huang; Jung-Chun Lin; Chih-Chien Lin
Journal:  Oncotarget       Date:  2017-06-29

Review 5.  East Asian Herbal Medicine to Reduce Primary Pain and Adverse Events in Cancer Patients : A Systematic Review and Meta-Analysis With Association Rule Mining to Identify Core Herb Combination.

Authors:  Hee-Geun Jo; Jihye Seo; Seulki Choi; Donghun Lee
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

6.  Increasing incidence of prostate cancer in Taiwan: A study of related factors using a nationwide health and welfare database.

Authors:  Po-Hung Lin; Su-Wei Chang; Ling-Hsuan Tsai; Hung-Cheng Kan; Jui-Ming Liu; Cheng-Keng Chuang; See-Tong Pang; Kai-Jie Yu
Journal:  Medicine (Baltimore)       Date:  2020-09-25       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.